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ABSTRACT By use of a model system consisting of giant vesicles adhering to ﬂat substrates, we identiﬁed, both experi-
mentally and theoretically, two new control mechanisms for antagonist-induced deadhesion. Adhesion is established by speciﬁc
binding of surface-grafted E-selectin and vesicle-carrying oligosaccharide LewisX. Deadhesion is achieved by controlled
titration of monoclonal antibodies against E-selectin. The ﬁrst mechanism is characterized by a considerable retraction of the
contact zone resulting in a loss of contact area between the vesicle and the substrate. Within the developed theoretical
framework, the observed equilibrium state is understood as a balance between the spreading pressure of the vesicle and the
antagonist-induced lateral pressure at the edge of the contact zone. In the second mechanism, the antibodies induce unbinding
by penetrating the contact zone without signiﬁcantly affecting its size. This process reveals the decomposition of the adhesion
zone into microdomains of tight binding separated by strongly ﬂuctuating sections of the membrane. Both experiment and
theory show a sigmoidal decrease of the number of bound ligands as a function of the logarithm of antagonist concentration.
The work presented herein also provides a new method for the determination of the receptor binding afﬁnity of either the
surface-embedded ligands or the competing antagonist molecules.
INTRODUCTION
Cell adhesion may be considered as a wetting process of a
complex ﬂuid droplet with surface bending elasticity. It is
governed by the interplay of many factors, such as numerous
generic interfacial forces (1,2) and membrane elasticity (3,4).
However, the key to the high speciﬁcity of cell recognition
relies on the topological and chemical complementarities of
proteins interacting at the interface of two cells. These in-
teractions, also called lock and key forces, can be formed by
bonds between identical (homophilic) receptors embedded in
opposing membranes, or between receptors and conjugate
ligands exposed on the surface of the cell (5).
The mobility of at least one binding partner involved in the
speciﬁc linkages is essential for the strengthening of adhesion
by the formation of adhesion patches. These patches allow
cells to rapidly form strong adhesion sites that can act as nu-
cleation centers for the subsequent formation of stress ﬁbers
and muscle-like actin-myosin assemblies. Such strengthen-
ing, mediated by the actin cortex, is essential for cells sub-
jected to strong hydrodynamic forces, as is the case for the
endothelial cells lining the inner surface of blood vessels. For
many processes deadhesion of whole cells or part of adhering
cells is necessary. A relevant example is the transient binding
of lymphocytes (T cells) to antigen-presenting dendritic
cells, which is associated with the formation of adhesion
domains called immunological synapses (6). Under physi-
ological conditions a T cell has to visit many antigen-
presenting cells before it is activated and starts to proliferate.
This requires the repeated adhesion and complete deadhesion
of the lymphocytes (7). An example of local detachments
is the unbinding of the trailing end of cells crawling on
surfaces, which is achieved by the uncoupling of the actin
cortex from the plasma membrane (8).
Given that the presence of only 104 speciﬁc adhesive mol-
ecules on the cell surface is sufﬁcient for the normal
functioning of the cell (4), the efﬁciency of the cell adhesion
mechanism is indeed stunning. To enable such sophistication
in the very noisy environment typical for the cell surround-
ing, several control mechanisms for cell adhesion must act
together. Key parameters in the process of cell adhesion are
the densities of the membrane-bound receptors (or ligands)
and repelling molecules. Furthermore, the adhesion can be
controlled by electrostatic forces and by antagonists com-
peting with the ligands for binding sites on the receptor.
The density of membrane-bound receptors and ligands in
the plasma membrane (and thus the adhesion strength) can
be controlled in various ways. First, by depletion through
internalization of receptor- (or ligand-) loaded vesicles budd-
ing from the plasma membrane (endocytosis) or, secondly,
by enhancement through the fusion of vesicles carrying
newly synthesized adhesion molecules within the plasma mem-
brane (9). Lastly, the density of receptors may be inﬂuenced
by proteolytic cleavage of ligands or receptor headgroups
(10).
The generic forces are controlled by the glycocalix. This
ﬁlm contains repelling molecules that can extend up to 40
nm into the extracellular space. Because the size of typical
receptors such as integrin or selectin is of the order of 10 nm,
the repellers can thus exert strong steric repulsive forces
between the adhering interfaces (3). An example of such
a repelling molecule is the antiadhesive glycoprotein CD43
expressed at the surface of human leucocytes (11,12).
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The repulsion produced by glycoprotein molecules is
strongly dependent on their size (Flory gyration radius).
Recently, Johnson and his collaborators have demonstrated
quantitatively that polysialylation (corresponding to an in-
crease in size) of the membrane-bound neural cell adhesion
molecule (NCAM) has a large impact on the adhesive pro-
perties of cells (13). Ultimately, at physiological ionic strengths,
the repulsion produced in this manner was sufﬁcient to
dominate both homophilic NCAM and cadherin attraction,
and obliterate the protein-mediated intermembrane adhesion.
These results support the putative role of NCAM poly-
sialylation in the regulation of cell adhesion and intermem-
brane space.
Repulsion forces can also be mediated by giant macro-
molecules of the extracellular matrix that bind to their
speciﬁc cell surface receptors. Hyaluronic acid, a highly
charged giant polysaccharide, which is recognized by the cell
surface receptor CD44, is an example of such a type of re-
pelling molecule. This species, which is known to play a key
role during embryonic development (14), can act as repulsive
spacer between cells thus impeding their adhesion. However,
if the interacting cells carry the appropriate polysaccharide
receptors, such as CD44, hyaluronic acid can also act as
attractive buffer and thus promote the cell adhesion (4).
Forces, both internally produced and externally exerted,
are necessary for normal cell functioning. For example, leuko-
cytes use the blood ﬂow in their search for inﬂammation, and
are thus submitted to large shearing forces while adhering and
rolling along the blood vessel (15). Fibroblasts that structure
the connective tissue, on the other hand, are able to pull strongly
on their surroundings when participating in the recovery pro-
cess of wounded tissue (16).
Although the biochemical and biofunctional aspects of
cell adhesion have been intensively studied for many years
(5,6,12,17), our knowledge of the physical basis of this ex-
tremely complex process is still rudimentary. Several im-
portant revelations in understanding the foundation of cell
recognition processes emerged from studies on model sys-
tems containing the essential ingredients of adhesion. These
consist of giant vesicles containing artiﬁcial or natural
receptors (or ligands) that act as test (or toy) cells interacting
with solid supported membranes or polymer cushions that
expose the conjugate ligand (or receptor) and thus can mimic
the target cell or tissue. The effect of the glycocalix is
accounted for by the incorporation of lipopolymers (lipids
exposing hydrophilic macromolecular chains) into the test
cell. The adhesion process is evaluated by reﬂection inter-
ference contrast microscopy (RICM), a microinterferometric
technique enabling the reconstruction of the surface proﬁles
of adhering soft shells. By analyzing these surface proﬁles in
terms of the theory of wetting of planar surfaces by partially
wetting ﬂuid droplets exhibiting surface (bending) elasticity,
the free energy of adhesion can be estimated (18–20).
The major experimental results of the model membrane
studies can be summarized as follows: adhesion inevitably
leads to receptor segregation resulting in the spontaneous
formation of adhesion plaques. The free energy of adhesion is
determined by the (nonideal) lateral osmotic pressure exerted
by the repelling molecules of the glycocalix and the unbound
receptors (or ligands). The glycocalix plays a key role in the
suppression of unwanted adhesion through the regulation
of the surface density of the receptors and the repelling
molecules. It enables the establishment of a situation near a
wetting transition, thus allowing nature to optimize the den-
sity of adhesion molecules. This suggests that the adhesion
strength can be controlled bymodiﬁcation of features such as:
i), the lateral densities of the receptors and repellingmolecules
in the cell surface, ii), the ratio of the hydrodynamic radii of
the repelling molecules to that of the receptors, and iii), the
bending stiffness of the membrane. These studies have
resulted in new insight into the physical basis of cell adhesion
and provided experimental evidence for theoretical predic-
tions based on the original work of Bell (21).
In a similar manner to adhesion, deadhesion is a process of
extreme importance for normal cell functioning. However,
deadhesion is, particularly from a physical point of view, a
much less studied, and hence a less well-understood process.
Nevertheless, several mechanisms for the control of dead-
hesion have previously been identiﬁed. In particular, the
control of the local adhesion strength and inducement of
deadhesion can be established through manipulation of the
extracellular matrix. For example, during embryonic de-
velopment, the deposition of ﬁbronectin as adhesive sites
guides cell locomotion during tissue growth. Another possi-
bility is the generation of new blood vessels by decomposi-
tion of adhesion-mediating macromolecules (e.g., collagen)
through proteolysis.
Deadhesion can also be regulated both by biomechanical
and mechanical mechanisms. Owing to the results of the
experiments on ﬁbroblasts of Rees and his collaborators, it
has been long known that the overall stiffness and shape of
the cell has a strong impact on the deadhesion process (22).
Furthermore, Crowley and Horwitz demonstrated that, also
for ﬁbroblasts, ATP rapidly destabilizes focal adhesions
through two distinct, but possibly interacting mechanisms
(23). The ﬁrst is the phosophorylation of several major
proteins by the activation of the tyrosine kinase cascade. The
second mechanism is cytoskeletal contraction that generates
tension. Apart from the role of the cytoskeleton, the area
constraint couples the tension and the adhesion strength of
the membrane of a given rigidity (24) and thus must in-
ﬂuence deadhesion. Furthermore, controlled tension is often
used in micropipette experiments to induce deadhesion and
study both intramembrane interactions (25,26), and inter-
actions between the cell membrane and the cytoskeleton
(27,28).
Competitive binders (antagonists) provide a very useful
tool to study the regulation of the cell morphology or the
polarity of protein distributions in the plasma membranes
by cell adhesion. In this connection, antibodies have been
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successfully applied to study the control of cell polarity by
cell-cell contacts and by adhesion of the cells with extra-
cellular matrix proteins such as laminin, collagen IV, and
heparin sulfate proteoglycans (29).
In contrast with the small effect that endogenous ligands
have on initiating cell attachment, they are likely to play
a large role in the deadhesion process. For example, Cai and
Wright propose a model for release of integrin-mediated
leukocyte adhesion in which endogenous ligands such as
elastase (expressed at the cell surface) are suggested to re-
lease adhesion by ‘‘eluting’’ the substrate-bound ligand from
the integrin and cause detachment (30). They show that the
elastase is capable of speciﬁc binding to the given integrins
and can thus compete with the ligand. This competition was
interpreted to represent a mechanism for deadhesion that is
additional to the proteolytic activity of these proteins.
This work is concerned with the physical origins of the
control mechanism of deadhesion provided by competitive
binders (antagonists). We are aiming to model the action of
antagonists (in the form of antibodies) and, in particular, their
ability to induce deadhesion of vesicles that are preadhered
by means of multiple ligand-receptor bonds. To achieve our
goal, as a ﬁrst step, we construct a simple system consisting
of a vesicle speciﬁcally adhering to the substrate. Speciﬁ-
cally, receptors of the selectin family (E-selectin) are im-
mobilized on a solid surface (acting as target cell) whereas
the conjugate ligands (sialyl-LewisX) are incorporated in
giant vesicles acting as test cells. As a source of competition,
monoclonal antibodies against E-selectin are used. After the
establishment of the ligand-receptor-mediated adhesion equi-
librium, antagonists are introduced into the surrounding solution.
Characterization of the new thermodynamic equilibrium has
shown that the antibodies used as antagonists are indeed re-
sponsible for a large impact on the adhesive properties of the
vesicles.
In a second step, a theoretical framework is constructed to
identify and rationalize the experimental outcomes and pro-
vide a quantitative background for the observed unbinding
mechanisms. This is achieved by extending the theoretical
considerations of Smith and Seifert for speciﬁc vesicle
adhesion (31), where the effective adhesion strength and the
average number of formed bonds is associated with the ap-
propriate shape of a vesicle in a thermodynamic equilibrium.
It will be shown, that by developing two somewhat similar
three-dimensional (3D)models for two distinct actions provided
by antagonists, it is possible to account for different observed
stages of the vesicle unbinding process and obtain very good
behavioral agreement with experiments.
MATERIALS
In this section we ﬁrst provide details of the preparations for the vesicle-
substrate system. To avoid repetition, the origin of the material used in the
preparations is summarized in a separate section.
Giant vesicles were prepared from an equimolar mixture of DMPC (1,2-
dimyristoyl-sn-glycero-3-phosphocholine) and cholesterol. To screen the
nonspeciﬁc Van der Waals attraction by the glass substrate, the vesicles were
doped with DMPE-PEG2000 (1,2-dimyristoyl-sn-glycero-3 hosphoethanol-
amine-N-polyethylene-glycol) by adding this lipid at a concentration of 1%
with respect to DMPC. In addition, to allow for speciﬁc ligand-receptor-based
binding of vesicles to the substrate, 8% of sialyl-LewisX-glycosphingolipids
(32) (sLex) were reconstituted into the bilayers. The vesicles were prepared
by electroswelling (33,34) in a 170 mOsm sucrose solution. To prevent
suppression of adhesion due to osmotic tension, the vesicles were placed in
a 210-mOsm salt buffer (100 mM NaCl, 1 mM CaCl2, 1 mM NaN3, 10 mM
HEPES at pH of 7.2). This was sufﬁcient to deﬂate the vesicles and enable
the formation of a contact zone parallel to the substrate. The vesicles were
deposited on the substrate from the suspension by sedimentation under
gravity.
The substrate was a clean glass coverslide that was hydrophobized by
immersion in a 1% toluene solution of aminosilanes (3-aminopropyltrie-
thoxysilane) for 4 min at 60C, which was followed by rinsing with pure
toluene and drying under N2 (35). Finally a recombinant form of the extra-
cellular domain of human E-selectin was physabsorbed on the substrate
exposing the silane layer (36). This was achieved by incubating the pro-
tein solution (maximum 5 mg/ml in the salt buffer) for 2 h at room tem-
perature, while the whole chamber was gently mixed on a shaking platform.
After rinsing with buffer, the substrate was incubated at room temperature
for an additional 1 h with a buffer solution containing 3% of blotting grade
blocker nonfat dry milk to prevent any direct contact of glass with the
vesicle. Final careful rinsing of the slide with buffer completed the prep-
aration.
For the competitive binding experiments, mouse anti-human E-selectin
was diluted in the salt buffer at concentrations of 10–25 mg/ml and inserted
into the measuring chamber with a Hamilton pipette.
All of the lipids and the cholesterol were purchased from Avanti Polar
Lipids (Alabaster, AL). The aminosilanes and toluene were obtained from
Fluka (Buchs, Switzerland), whereas the coverglasses originated from
Merck (Darmstadt, Germany). E-selectin was made by Calbiochem (San
Diego, CA), whereas the antibodies were manufactured by Chemicon
(Temecula, CA). The Millipore water used for rinsing and the buffers was
prepared with a system from Millipore (Molsheim, France). The fat-free
milk was purchased from BioRad (Hercules, CA). Additional details of the
preparation and the characterization of both the vesicles and the substrates
can be found in the thesis of Lorz (20) and will be discussed elsewhere (37).
METHODS
To examine deadhesion of the vesicle, RICM has been used. This micro-
interferometric technique generates an interference pattern by interference of
light waves reﬂected at the interfaces between the substrate and the buffer,
and the buffer and the membrane. It allows for the reconstruction of the
surface proﬁles of adhering bodies with;10 nm out of plane and ;0.3 mm
in-plane spatial resolution. Relative membrane displacements in the vertical
direction can be measured with resolutions of up to 5 nm. The spatial
variations of the substrate-membrane distances can be directly visualized
through the variations of grayscales that can be represented in terms of 255
grayscale colors. Strongly bound parts of the membrane appear as dark
regions of the interference pattern whereas weakly adhering regions sepa-
rated from the substrates by ;100 nm appear as gray areas. In combination
with fast image processing thermally excited membrane ﬂuctuations can be
analyzed quantitatively to evaluate the control of adhesion by the undulation
forces.
The bottom of the 900-ml measuring chamber is formed by a coverglass
pressed onto a Teﬂon frame by a metal ring. The chamber is mounted on an
inverted Axiomate 100 microscope (Zeiss, Jena, Germany), equipped with
an antiﬂex objective (Plan Neoﬂuar, 633 /1.25 Oil, Zeiss). The inter-
ferograms are observed with a Peltier-cooled 10-bit charge-coupled device
camera (C4880-80, Hamamatsu Photonics, Hamamatsu, Japan) and the
digitized images are stored directly using real-time imaging software (38).
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EVALUATION OF CHANGES IN THE
ADHESION ZONE
Before the formation of ligand-receptor bonds, the vesicle
settles at a height governed by the effective potential acting
between the membrane matrix and the substrate. Due to the
passivity of the substrate and the repulsion exerted by the
glycolipids reconstituted into the membrane, the minimum
of this potential is sufﬁciently far from the substrate.
Consequently, the vesicle is weakly bound and still exhibits
strong undulations (39). After some time, ligand-receptor
bonds begin to form. The adhesion process associated with
these speciﬁc binding results in aggregation of the ligand-
receptor pairs leading to two types of adhesion zones within
the adhesion disk (see Fig. 1 B). In the ﬁrst type, the vesicle
membrane is locally trapped in patches of strong adhesion
generated by receptor-ligand bonds formed while the
undulations are almost totally suppressed (3). In the second
type of contact, the membrane outside of the patch remains
in the initial stage of weak adhesion and is subject to
ﬂuctuations (see Fig. 1 B). When the formation of patches
dominates the overall effective potential, the patches of
strong adhesion grow beyond the initially established contact
zone between vesicle and substrate, inducing a ﬁrst-order
shape transition (18,19). For the vesicles whose adhesion
is mediated by the sLex-E-selectin pair, such transitions
occur for high coverage of the substrate and a relatively
large fraction of ligands in the vesicle (37). When the equi-
librium is attained, the contact zone is maximized and
appears uniform within the resolution of the microscope (see
Fig. 1 C).
The transition from the weak to the strong adhesion state
for a certain point in a vesicle can be easily seen by moni-
toring changes in the membrane ﬂuctuation amplitude. This
is demonstrated in Fig. 1 D where the membrane height of a
given point (in the contact zone) is measured over time. The
transition obviously occurs around t ¼ 1300 s. From this
graph it is possible to construct a histogram of heights (see
inset of Fig. 1 D) that clearly shows a Gauss-like peak that
belongs to the bound state.
Antagonist-induced unbinding
Once a steady state of adhesion is reached, small amounts of
antibodies are added to the buffer solution. The mouse anti-
human E-selectin is capable of blocking the sLex binding
site of E-selectin, which may lead to the unbinding of the
receptor-ligand bonds. Indeed, upon insertion of antibodies
into the solution, three phases of unbinding of the vesicle
(denoted as phases I–III) are observed.
Phase I: lateral pressure mechanism
Phase I is characterized by a decrease in size of the contact
zone. This is particularly apparent in the ﬁnal row of Fig. 2,
where the edge of the vesicle contact zone before the
antibody insertion is compared with the edge of the contact
zone at the end of this phase. During this time, the contrast
within the inner part of the contact zone is not altered.
Instead, the entire adhesion plate still appears to be strongly
bound, indicating the persistence of the ligand-receptor
bonds inside this region (see the second row in Fig. 2).
Because both the coverage of the substrate with E-selectin
(;3000 molecules/mm2 as estimated by Lorz (20)) and the
concentration of ligands in the vesicle (10 mol%), are rela-
tively high, the contact zone must be relatively densely
packed with bonds. Diffusion of molecules of the size of
antibodies is thus strongly suppressed in comparison to the
diffusion in the bulk solution, impeding their access to
E-selectin in the contact zone. In this short initial stage (;3
min), the action of the antibodies occurs merely at the rim of
the adhesion plate, whereas the remaining part of the zone
appears impermeable. Apparently, the antibodies binding to
the substrate begin to exert a lateral two-dimensional (2D)
pressure on the rim of the contact zone, resulting in the
reduction of the excluded area of the adhesion plate. The
ﬁnal size of the zone is determined by the balance between
the antibody pressure and the spreading pressure of the
vesicle.
Although phase I can be clearly distinguished in experi-
ments, it is somewhat difﬁcult, from a technical point of
FIGURE 1 Different stages of the adhesion process of a single vesicle.
The scale bar indicates the length of 10 mm. (A) The bright ﬁeld picture of
the vesicle. (B) Coexistence of a patch of strong adhesion (dark) and region
of contact of the weak adhesion (bright area exhibiting interference fringes).
(C) Adhesion after the shape transition induced by the growth of the patch to
its maximum size associated with the aggregation of the ligand-receptor
bonds. (D) Height of the membrane as a function of time for a square point
that is shown in panels B and C. The inset contains the resulting histogram of
heights. The bound state is deﬁned by the peak in the distribution and is
shaded in gray.
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view, to determine exactly when it ends. The technique em-
ployed is very sensitive to membrane ﬂuctuations exhibited
by the parts of the membrane that are not speciﬁcally pinned
to the substrate. However, as the initial density of bonds
is relatively high, a very small number of sLex-E-selectin
bonds may be replaced by antibody-E-selectin bonds before
the ﬂuctuations reach observable amplitudes (;5 nm with
this setup). Furthermore, in case of midrange density of bonds,
it is to be expected that there will be a very short period of
time when the antibodies penetrate the contact zone while the
rim is still retreating. Ultimately, these two processes will run
simultaneously, which is, within the scope of the article,
identiﬁed as phase III.
Phase II: competitive binding mechanism and phase III
Phase II is a much slower regime of the deadhesion process
and begins when the antibodies penetrate the contact zone.
During this period (lasting ;20 min), the vesicle and the
antibodies are seeking a new equilibrium and this process
is driven by the chemical potential provided by the anti-
bodies in the bulk solution. Although it is found that the size
of the total contact zone remains almost unaltered (see the
overlapping edges in the last row of Fig. 2), the distribu-
tion of the bonds gradually changes from uniform to highly
structured. The higher afﬁnity of the antibodies for E-selectin
causes the number of sLex-E-selectin bonds to decrease.
After some time, the vesicle ﬁnds a new equilibrium and
FIGURE 2 Unbinding of a vesicle by antibody titration. Injections of the antibody solution are marked with thick arrows in the top part of the ﬁgure. The
scale bar in the top left frame indicates the length of 10 mm. The three phases of the unbinding process are indicated with red Roman numbers. In the ﬁrst row,
the original RICM images taken at the times (minutes and seconds) indicated at the bottom of each image, are presented. The strong adhesion zones are
extracted in the second row, whereas the rims of the contact zone are presented for the corresponding frames in the third row. The edge of the blister in the
middle of the zone is shown for the purposes of facilitating the orientation. The rims for each phase are superimposed in the last row, with the thin arrows
indicating the frames superimposed. Phase I is a short phase where the antibodies are acting on the rim of the contact zone merely as a lateral two-dimensional
pressure. In phase II the spreading pressure of the vesicle equilibrates with the lateral antibody pressure. In this slow phase, the antibodies are penetrating the
adhesion patch, and the deadhesion occurs as competitive binding of antibodies to receptors. Phase III occurs upon a further increase of antibody concentration.
At this stage, both mechanisms (the receding of the rim and the penetration of antibodies into the whole adhesion zone) are in action. Details of analysis used for
construction of this ﬁgure can be found in Appendix A.
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no further change in the structure of the contact zone is
visible.
Further increasing the antibody concentration after the
equilibrium has been achieved in phase II, induces a tran-
sition of the vesicle into phase III of the deadhesion process.
At this point, the contact zone becomes highly permeable to
antibodies, but the excluded area is still relatively large.
Under these circumstances, both the lateral pressure mech-
anism that dominates phase I, and the competitive binding
mechanism prevailing during phase II can act simulta-
neously. Considerable loss of both the size of the contact
zone and the number of bound ligands can therefore be ob-
served. The latter process can be identiﬁed by the change in
contrast within the contact zone, and an increase of white
area in the second row in Fig. 2. The size changes are evident
from the overlapping edges from this phase (last row of
Fig. 2).
The area of strong adhesion occupying the entire contact
zone remains uniform during phase I. In phase II, however, it
gradually decomposes into a very large number of micro-
domains. After a certain time during phase II the formation
of microdomains saturates and the number of newly formed
microdomains is negligible in comparison to those detaching
from the substrate. This is demonstrated in Fig. 3 where
a highly structured contact zone from the beginning of phase
II is compared to the one from phase III. Although the size of
the patch has been considerably reduced over 30 min, all of
the microdomains persisting into phase III can be traced in
the earlier picture from phase II. At the same time, only a few
microdomains (indicated in Fig. 3 with yellow circles) were
formed. Interestingly, the membrane retracts only by the loss
of a whole microdomain at once, which means that a micro-
domain must have a critical minimum size. The membrane
released in the detachment of microdomains is able to
ﬂuctuate, particularly where large holes appear in the patch.
This is responsible for the light blue colors in Fig. 3.
The binding and unbinding events of a surface element of
the membrane can also be seen in the ﬂuctuation diagrams
(right-hand side of Fig. 4), where typical examples are pre-
sented. The unbinding is usually a prompt (Fig. 4, A and C).
However, in some cases, gradual unbinding has also been
observed (Fig. 4 B). Rebinding events are also recorded
such as the case shown in Fig. 4 C around t ¼ 500 s. For
each ﬂuctuation diagram, the height histogram is also pre-
sented on the left side of Fig. 4. For all cases, the bound state
was long lived so that there is a clear maximum. Because
all points belong to the same vesicle, the cutoff for the
bound state (end of gray area) is the same for every point in
Fig. 4. Details of these analyses can be found in Appendix A.
If the experiment is repeated with half of the previous
concentration of receptors on the substrate, somewhat dif-
ferent behavior is observed. In this case, as shown in Fig. 5,
before the insertion of antibodies one observes an assembly
of strong adhesion patches with a total area smaller than that
of the contact zone. When added, the antibodies almost im-
mediately penetrate into the patch, thus circumventing phase
I. This is due to the smaller concentration of bonds within the
patch resulting from the decreased coverage of the substrate
by E-selectin. Furthermore, the appearance of microdomains
is observed almost immediately upon insertion of antibodies,
but the size of the contact zone remains virtually constant
throughout the entire experiment.
By subsequent addition of small aliquots of titer (1 mg of
antibodies each time) and waiting until the new equilibrium
was established on each occasion, the variation of the total
area of the strong adhesion patches with the number of
aliquots was constructed (Fig. 5). Because the area of the
patch is proportional to the number of formed bonds, and the
concentration of the antagonist is proportional to the weight
of inserted antibodies, the sigmoidal curve in Fig. 5 reﬂects
the functional dependence of the number of bonds on the
antibody concentration. Unfortunately, due to difﬁculties in
determining the absolute concentration of active receptors
on the substrate, it is only possible to roughly estimate the
number of bonds present. The discussion of this and asso-
ciated aspects will be deferred until later.
FIGURE 3 An overlay of two pictures of the contact zone dominated by
ligand-receptor interactions. The two superimposed images are shown in top
left and top right corners together with their relative times when the
snapshots were taken. For better visualization, the gray color scale from
the original pictures has been transformed into either a red or a blue scale.
The pictures were then made transparent and overlaid. Where the two
pictures overlap, the gray colors emerge. The intensity of the colors reﬂects
the strength of binding. For details see Appendix A.
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It can be seen from Fig. 5 that most of the patch area is lost
after the addition of the third and fourth titers. Upon insertion
of the third milligram of antibodies, the area of the patch
saturates to;55% of its initial value, whereas after the fourth
milligram the original area is reduced by 90%. Interestingly,
ﬁve further aliquots are not sufﬁcient to completely destroy
the patch resulting in unbinding of the vesicle. This is
attributed to the fact that the concentration of free ligand in
the vicinity of the patch (and in the vesicle) is much larger
than the concentration of antibodies. Hence, the rebinding
events occur much more frequently and are able to com-
pensate for the lower binding afﬁnity. In addition, the pres-
ence of 10 mg of antibodies begins to change the osmolality
of the bulk solution and hence the reduced volume of the
vesicle. At this stage, the experiment must be abandoned as it
is not possible to maintain constant vesicle volume, and thus,
the size of the contact zone changes not because of the
binding of the antibodies to the surface but rather the in-
creased osmotic pressure difference between the inner and
outer buffer solutions.
Similar experiments have been performed with ﬂuores-
cently labeled soluble sLex molecules as antagonists to the
membrane incorporated sLex (data not presented). However,
ﬂuorescence measurements were unable to produce reliable
data because of strong bleaching and insufﬁcient spatial
resolution. In contrast, RICM data indicate that this system
exhibits the same qualitative behavior as the one previously
described, with the caveat that much larger concentration of
the antagonizing sLex had to be used in comparison to
antibody concentrations. This is to be expected as the bind-
ing constant of sLex to E-selectin is much smaller than that
of the antibody to the E-selectin.
THEORETICAL CONSIDERATIONS
To better understand the observed results, two similar 3D
models are developed to account for the deadhesion mech-
anisms dominating phase I and phase II. In particular, explicit
consideration is given to the following factors: i), the enthalpy
of binding of both ligands and antagonists; ii), the mobility of
the ligands and the antagonists through a contribution to the
mixing entropy; iii), the ﬁnite number of ligands contained in
the vesicle, iv), the constant density of immobile receptors on
the substrate, v), constant chemical potential of antagonists in
the bulk solution, and vi), the bending energy of the vesicle
shape. In this manner, the continuous approach of Seifert and
Lipowsky (40) is connected with the thermodynamic approach
of Bell and Dembo (41,42). The equilibrium conditions of the
described ensembles are obtained by minimizing the free
energy of the system in an appropriate manner. The average
number of formed bonds is thus obtained as a function of the
constituent concentrations and the effective binding strengths
of a single antibody-receptor and ligand-receptor pair.
In both cases the vesicle surface is separated into a region
parallel to the substrate forming a contact zone and a region
consisting of the remaining part of the vesicle. The inter-
actions of ligands with receptors are assumed to occur only
within the contact zone. Nevertheless, the regions are able to
exchange ligands and area. The antagonists are permitted to
interact with the receptor only when absorbed on the sub-
strate. The contribution to the internal energy of the system
from a single bond is realized whenever a ligand or an anti-
body is positioned over a receptor site.
FIGURE 4 Height of a membrane as a function of time for three different
points in the contact zone of a same vesicle (left). Height histograms
corresponding to the graphs on the left are given on the right, respectively.
The part of the graphs shaded in gray are associated with the bound state.
FIGURE 5 Area of the adhesion patch as a function of the concentration
of antibodies. The scale bar indicates the length of 10 mm. Data points are
shown as inverted triangles. The line connecting the triangles is a sigmoid
ﬁtting function. Four original pictures are presented together with the pattern
of strong adhesion patches that were extracted by image processing. Every
data point was processed in exactly the same way and the error associated
with each one is proportional to the ratio of the surface to the circumference
of the patch. The arrows connect a given point with the original picture.
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In the absence of antagonists, both models should reduce
to the recently developed thermodynamic model for the
equilibrium state of vesicle adhesion (31). Several results
from that work are pertinent to modeling of vesicle adhesion
in the presence of antagonists. In particular, in the work in
question, it has been found that the magnitude of the bending
energy term is usually much smaller than that of the others in
the free energy, and can generally be ignored (31). The only
exception is when the shape of the vesicle approaches the
shape of a spherical cap for which the bending energy
diverges inducing a boundary minimum in the free energy
with respect to size of the contact zone. As a consequence, in
the thermodynamic equilibrium, the vesicle area of contact
with the substrate is maximized and determined only by the
reduced volume of the vesicle.
The experimental procedure described in the previous section
has shown that it is virtually impossible to completely screen the
nonspeciﬁc interaction between the substrate and the vesicle.
This interaction is responsible for the formation of the relatively
small initial contact zone (see Fig. 1 B). The vesicle can ﬁnd the
thermodynamic equilibrium governed by the diverging bending
energy (as in the case of the vesicles in Figs. 1 C and 2 at
t ¼ 0.00), where bond formation completely dominates the
nonspeciﬁc interaction of the vesicle with the substrate. The
adhesion process resulting in such adhesion plates is generally
fast and uninterrupted. The ﬁnal contact zone is usually uniform
and densely packed with ligand-receptor pairs, and the shape of
the vesicle is a spherical cap. The unbinding of such a vesicle
by means of antagonists is determined by the mechanism that
governs phase I and it is only later that such a vesicle can par-
ticipate in phases II and III (as seen in Fig. 2).
There are often cases, however, when the vesicle appears to
be in its equilibrium state without assuming the shape of the
spherical cap (see, for instance, the vesicle in Fig. 5). The
adhesion process associated with such a state is usually slow
and stepwise, and should be expectedwhen the probability for
bond formation is reduced, either due to the low coverage or
a low fraction of ligands in the vesicle. Technically, the slow
equilibration leads to a relaxation of the free energy with
respect to ligand density variables but not with respect to the
size of the contact zone. In this constrained equilibrium,
the distribution functions resulting from the minimization of
the free energy are still valid, but the size of the contact zone is
not determined by the bending divergence but by factors such
as the nonspeciﬁc interaction potential, shape ﬂuctuations,
and the probability for bond formation. Axially symmetric
shapes of vesicles in this constrained equilibrium (obtained
for a ﬁxed size of the contact zone) can be determined by the
use of a continuummodel (40)where the bending energymust
be minimized for a chosen size of the contact zone.
The conditions for these two different equilibria in the
experimental system discussed in previous sections have been
explored in detail and are discussed elsewhere ((20), and B. G.
Lorz, A.-S. Smith, C. Gege, and E. Sackmann, unpublished).
However, it is important to emphasize that the proposed
adhesion model for vesicle adhesion (31) could be applied to
both the thermodynamic and the constrained equilibria. It is
with this in mind that we proceed with our thermodynamic
considerations.
The models for the deadhesion mechanisms dominating
phase I and phase II are developed within the same frame-
work as was undertaken for describing simple adhesion.
However, for the unbinding mechanism of phase I, the size
of the contact zone is determined by the equilibration of the
spreading pressure of the vesicle and the lateral pressure of
the antibodies. The latter is the gain in the free energy if the
area of the contact zone is reduced for the area of a single site
and is similar to the chemical potential in condensation
process. For the unbinding mechanism of phase II, the size of
the contact zone is taken to be constant and the number of
formed ligand-receptor bonds is determined simultaneously
with the number of antibody-receptor bonds.
The lateral pressure mechanism: phase I
Under the condition of an impermeable adhesion plate (high
density of ligand-receptor bonds), the added antibodies exert
lateral 2D pressure on the edge of the contact zone (see Fig.
6), without penetrating the bulk of the zone. The vesicle,
FIGURE 6 The balance between the spreading pressure of the vesicle (v)
and the lateral antibody pressure (P) determines the size of the contact zone.
Antibodies are not penetrating the contact zone and are presented with
yellow-black triangles. Red triangles in the vesicle indicate ligands and give
rise to the fraction nt. The green sites in the substrate can be associated with
receptors that contribute to rr. Antibodies can either be speciﬁcally bound to
the substrate by forming an antibody-receptor bond and contributing to pb, or
they can be nonspeciﬁcally absorbed to the sites on a substrate that are free
of receptors giving rise to pf. The contact zone sc is depicted as the part of
a vesicle at zero distance from the substrate. If, within this area, a red triangle
is on top of a green site, a bond is formed that contributes to nb. A red
triangle over a white site indicates a free ligand in the contact zone and can
be associated with nf. Opposing white and gray arrows at the edge of the
contact zone indicate the two balanced pressures.
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however, tries to maintain the size of the contact zone by its
spreading pressure. Therefore, in the presence of antibodies,
the system must ﬁnd a new thermodynamic equilibrium.
This competition typically results in a smaller size of the
vesicle contact zone. In the case that the antibody pressure is
very high, the vesicle will lose the entire contact zone and
detach from the substrate.
For the quantitative modeling we will use the following
notation:
Eb, antibody-receptor binding energy (in units of kBT).
Cv, volume fraction of antibodies in the solution.
rr, fraction of the substrate surface covered by receptors.
pb, fraction of the substrate surface covered by adsorbed
antibodies bound to receptors.
pf , fraction of the substrate surface covered by adsorbed
antibodies not bound to receptors.
pa, total coverage of the substrate by adsorbed antibodies,
pa ¼ pb1pf .
St, total number of sites in the vesicle. A site has the size
of the ligand.
sc, the fraction of the total vesicle area forming the
contact zone, 0 # sc # 0.5. (For a speciﬁcally
adhered vesicle in the thermodynamic equilibrium,
sc ¼ 0 if v ¼ 1 and sc ¼ 0.5 only for v ¼ 0.)
Ea, ligand-receptor binding energy (in units of kBT).
nt, total vesicle surface coverage by ligands (e.g., for nt¼
0.1, 10% of the vesicle surface is covered by ligands).
nb, fraction of total ligands that are in the contact zone
and bound to receptors (e.g., for nb ¼ 0.1, 10% of
all ligands in a vesicle are bound to the substrate).
nf, fraction of total ligands that are in the contact zone
and free.
All of the variables that are expressed as fractions adopt
values in the range between 0 and 1.
The spreading pressure of the vesicle
Because the 3D vesicle spreads over a 2D surface, the lateral
spreading pressure is of a two-dimensional nature. The latter
is deﬁned as the work required for changing the vesicle-
substrate contact area which must be determined from the
model for vesicle adhesion in the absence of antibodies. Thus,
it is equivalent to the effective adhesion strength resulting
from binding of receptors to the substrate as deﬁned pre-
viously (31). As this previous work contains an overview of
the relevant literature as well as a thorough characterization of
the behavior of the calculated spreading pressure, we will not
reproduce this material in full herein. We will, however,
outline the elements of themodel pertinent to the unbinding of
speciﬁcally adhered vesicles by ligand antagonists.
The fraction of bound ligands and free ligands in the
contact zone is given by the following expressions:
nf ¼ ð1 nbÞscð1 rrÞ
1 scrr
: (2)
These can be used to determine the vesicle spreading
pressure that is, in units of kBT/a (a is the area of a site),
found to obey:
v ¼ rr ln
rr
1 rr
 ln rrsc  nbð1 rrÞsc  nf
 
: (3)
Importantly, the spreading pressure always increases mono-
tonically with decreasing size of the contact zone. The maxi-
mum is always at sc¼ 0 and is given by the following expression:
v0 ¼ rr ln½ eEa  1
 
nt1 1: (4)
It is this spreading pressure that needs to be overcome to
detach a vesicle.
The lateral antibody pressure
The calculation of the 2D lateral antagonist pressure P is
analogous to determining the Langmuir absorption isotherm
of particles interacting with a substrate (43). The antagonists
binding to the receptors (pb) and antagonists absorbing to the
receptor-free part of the substrate (pf) need to be in equi-
librium with the very dilute antibody solution, for which the
ﬁxed chemical potential m ¼ ln Cv is assumed to be ﬁxed.












It is by deﬁnition the gain in the free energy realized when
the system increases its available size for a surface area of
a unit site and is found to be given by the following ex-
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strate by antagonists and the antagonist spreading pressure is
given in Appendix B. However, it is important to notice that
the lateral pressure deﬁned by Eq. 6 will be valid only for
relatively low concentrations of the antagonists (Cv , 0.1)
and completely determined by the system parameters (the
antagonist-receptor binding strength, surface coverage, and
the concentration of antagonists).
Determining the size of the contact zone
The equilibrium size of the contact zone seqc and the fraction
of bound ligands neqb in the presence of antibodies can be
determined by solving v ¼ P. A typical result of such
a calculation is presented in Fig. 7 where neqb and s
eq
c are
shown as functions of the antibody concentration, for given
concentrations of ligands and receptors. As the initial size of
the contact zone is associated with the shape of the spherical
cap, the reduced volume of the vesicle determines the size of
the contact zone before the insertion of antibodies.
The critical concentration of antibodies Cv* necessary for
the detachment of the vesicle can be determined by solving
v0¼P. This concentration is found to depend on the ligand-
receptor and antibody-receptor binding strengths as shown in
Fig. 8.
Importantly, the logarithm of the critical concentration
decreases linearly with increasing antibody-receptor binding
strength (left panel in Fig. 8). Moreover, it is possible to
detach the vesicle even with antagonists of lower binding
strengths than that characterizing the ligand-receptor pair
(Eb, Ea), but that would require higher antibody concentra-
tions. However, there is a minimum strength of antibodies that
need to be available in order for detachment to be achieved.
When the detachment concentration is explored as a func-
tion of the ligand-receptor binding strength (right panel in
Fig. 8), the critical concentration approaches zero very rap-
idly, for large differences between the two binding strengths.
After this divergence at low ligand binding strengths, the
logarithm of the critical concentration enters a linear regime.
This linear regime ends in another divergence, this time at
ligand binding strengths somewhat larger than the antibody
binding strength. This result demonstrates the insensitivity of
the system to the presence of the relatively weak antibodies.
The competitive binding mechanism: phase II
The penetration of antibodies into the contact zone may
occur upon a spontaneous unbinding of the ligand-receptor
pair, even after the spreading pressures are equilibrated. To
account for this effect we have expanded the model for
adhesion to allow for competitive binding within the contact
zone of a constant size (see Fig. 9). The size of the contact
zone (sc) is maintained by the same mechanisms as discussed
in previous sections. The ligands are still treated as a part of
a ﬁnite system while the antibodies are coupled to the solu-
tion of a constant chemical potential.
FIGURE 7 (A) The vesicle spreading pressure v as a function of the size
of the contact zone sc. (B) Antagonist lateral pressure P as a function of the
antagonist bulk concentration Cv. (C) Equilibrium size of the contact zone
seqc and (D) equilibrium fraction of bound ligands n
eq
b as function of the
antagonist bulk concentration Cv. Chosen binding strengths and concen-
trations of other ligands and receptors are indicated in the bottom of the
ﬁgure. For the given parameters, there is a certain concentration (Cv 107)
at which the size of the contact zone is signiﬁcantly inﬂuenced by the
presence of the antibodies. The fraction of bound ligands, however, changes
at somewhat larger concentrations (Cv 106), indicating an increase of the
density of ligand-receptor bonds in the contact zone, accompanied by an
increase of the average spreading pressure, even when the zone is reduced.
FIGURE 8 The logarithmic plot of the critical (detachment) concentration
of antibodies as a function of the antibody-receptor binding strength (left)
and as a function of the ligand receptor binding strength (right). The
divergence of the Cv* at both low antibody-receptor and ligand-receptor
binding strengths as well as the maximum ligand-receptor binding strength
for which detachment can occur is clearly visible. The parts of the diagrams
with shaded backgrounds indicate the regions of parameters where the
vesicle is bound to the substrate, whereas the white background signiﬁes free
vesicles. Dashed lines indicate the choice of the binding strength of the
ligand-receptor pair (left) and the antagonist-receptor pair (right).
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Minimizing of the appropriate free energy (see Appendix
C for details) is a task beyond the analytical approach
undertaken this far. However, it is possible to ﬁnd expres-
sions for the fraction of area occupied by antibodies in the
contact in the same form as those obtained for the non-
permeable contact zone:















The difference between Eqs. 5 and 7 is that the coverage
of the surface accessible to bound and free antagonists is
reduced by the presence of bound and free ligands (nb and nf,
respectively).
The fraction of bound ligands is determined simulta-
neously and is presented in Fig. 10, where nb is calculated for
the case of titration with antibodies of different binding
strengths, while all other parameters are kept constant. It is
this nb that must be used to determine pb from Eq. 7.
It is surprising that the increase of Eb provides only a shift
of the decay function of bound ligands toward smaller con-
centrations. This shift is linear with respect to the antibody
binding strength and is equal to Eb lnCv 1 const. However,
an increase of more than ﬁve orders of magnitude in the
concentration of antibodies is needed for the complete un-
binding of ligands. Nevertheless, most of the ligand bonds
are lost in a relatively short window of two orders of
magnitude in the antibody concentration. When Cv/ 0, the
model for adhesion in the absence of antibodies, presented in
Smith and Seifert (31), applies.
Several important properties of the decay functions can be
learned from the double logarithmic plot (Fig. 11). It is easy
to notice that the slope of the decay function remains almost
constant despite the widely varying choice of parameters
(presented for each curve in Table 1). This linear slope of the
decay functions also suggests that it is not possible to com-
pletely block the receptors on the substrate from the ligands.
However, this cannot be realistic as at some stage nb will
become small enough to give rise to less than one ligand
bound to the substrate. Furthermore, in this limit, the ther-
modynamic laws on which this approach is based are ex-
pected to fail due to insufﬁcient statistics with small
numbers.
The analysis of the calculated data shows that the relation
ðnbÞ=ðrrÞ ¼ const: is valid for the entire range of antibody
FIGURE 9 A schematic representation of the competitive binding
mechanisms. The antibodies are penetrating the contact zone blocking the
receptors for the ligands. The contact zone remains of constant size. The
concentrations (pf and pb) of antibodies in the contact zone is in chemical
equilibrium with the antibodies in the solution.
FIGURE 10 Fraction of bound ligands as a function of the antibody con-
centration for different antibody-receptor binding strengths. Other parameters
are kept constant and are indicated in the graph.
FIGURE 11 Double logarithmic plot of the fraction of bound ligands as
a function of the antibody concentration for different antibody-receptor
binding strengths, for different sets of parameters. The parameters for each
curve are given in Table 1 with the corresponding number.
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concentrations and allows the prediction of the number of
bound ligands if data for an analogous system are available.
The scaling law with respect to the total fraction of ligands
ðnbÞ=ðntÞ ¼ const: in the vesicle is, however, correct only in
the linear regime of Fig. 11.
DISCUSSION AND SUMMARY
We have demonstrated that the adhesion strength of soft
shells mediated by speciﬁc (lock-and-key) forces can be
modulated, in a dose-dependent manner, by the action of
a ligand antagonist (in the form of an antibody). As the two
theoretical models developed herein are able to rationalize
both unbinding processes observed in our experiments, we
can be reasonably conﬁdent that the main physical aspects of
the problems are well accounted for. Particularly striking is
the agreement between the theoretical predictions (Fig. 10)
for the dependence of the number of ligand-receptor bonds
on the concentration of the antibody solution, and the
observed behavior of the vesicle (Fig. 5). In the latter ﬁgure,
the area of the patch is presented as a function of the mass
concentration of antibodies. Due to difﬁculties in determin-
ing the surface coverage, it is hard to determine the exact
number of bonds within the patch. However, as the coverage
is uniform on the micrometer length scale, the number of
bonds must be proportional to the patch area on the same
scale. Furthermore, as mass concentration is evidently pro-
portional to the volume concentration of the antibodies in the
solution, the excellent qualitative agreement between the
theoretical approach and the presented experiments is clearly
visible. In both cases, as the concentration of antibodies is
increased, an initial rapid loss of bonds is followed by a much
slower regime for bond detachment.
The experimental method of vesicle unbinding by anti-
body titration, supported by the theoretical models provides
a useful technique for determining important properties of
the system. First, the antagonist titration experiments are
useful to visualize the formation or dissolution of adhesion
microdomains. The adhesion model in the absence of anti-
bodies should provide information concerning the ligand-
receptor binding strength and the gain in the effective
adhesion strength, also called spreading pressure of the
vesicle (3,31). Although it is not possible to exactly deﬁne
the required quantities (such as density of receptors) with this
experimental setup, the utility of the approach can neverthe-
less be demonstrated for the vesicle in Fig. 2 by considering
a relatively large range for each quantity and assuming that
every receptor in the adhesion patch is, before titration,
bound to a ligand. Thus, by assuming a radius of gyration of
the ligand between 3.5 and 4.5 nm, with 3000–4000 re-
ceptors on 1 mm2 of the substrate surface, Eq. 1 provides an
estimate of the sLex-E-selectin binding strength of 2–6 kBT.
This value is of the same order of magnitude as the binding
strength between P-selectin and cell-surface molecules ex-
posing polypeptide headgroups with sLex side chains. In
addition, unbinding forces of 4–5 kBT for a single P-selectin-
sLex bond were recently measured with force spectroscopy
(28,44). Our result is useful in the sense that it clearly dem-
onstrates that the theory developed herein certainly provides
the correct order of magnitude for the binding strength of
a single bond.
The theoretical description of vesicle deadhesion provides
a method for determining several other important parameters
of the system. In the case that the ligand-receptor binding
strength is successfully determined, the binding strength of
the inhibitor can be found. If the antibody-receptor binding
strength is known, deadhesion can also be used as an alter-
native approach for determining the ligand binding strength
and the spreading pressure of the vesicle. By choosing both
a ligand and an antibody with known binding strengths, the
quality of the receptor coverage could also be probed. How-
ever, the range of the above estimates for the binding
strengths and the coverage in these experiments is too large
to result in well-deﬁned predictions. Though further elab-
oration would be clearly desirable, this work provides the
foundation for systematic experimental measurements of the
binding strengths of both antagonists and ligands.
Using the same estimates for the surface coverage as
above, Eq. 3 provides the spreading pressure of the order of
105 Nm1, which is in agreement with the state of strong
adhesion observed in Fig. 2. The analysis of the experimental
data obtained for the vesicle from Fig. 2 by the use of an
independent technique for the evaluation of the average
adhesion strength (from the reconstruction of the vesicle
height proﬁle at the edge of the contact zone (39)) suggests
that the spreading pressure of the vesicle in equilibrium at the
beginning of phase I is less than the one evaluated from the
equilibrium at the end of phase I. The theoretical model (31),
clearly shows that the spreading pressure of the vesicle (e.g.,
average adhesion strength) is always increasing with a de-
creasing size of the contact zone (see Fig. 7 A). This is es-
sential to balance an additional lateral pressure induced by
titration of antibodies. As a new equilibrium is experimentally
observed (end of phase I), one may conclude that at least
qualitative agreement between the models and the experi-
mental data is obtained.
The above result is interesting in the context of previous
measurements of the receptor-ligand binding strength based
TABLE 1 Parameters of the curves given in Fig. 11
Curve Ea Eb nt rr sc
1 5 15 0.1 0.5 0.15
2 5 15 0.1 0.5 0.25
3 5 15 0.01 0.5 0.15
4 5 15 0.01 0.5 0.05
5 1 15 0.1 0.5 0.15
6 1 15 0.1 0.1 0.15
7 1 20 0.1 0.1 0.15
The number in the ﬁrst column corresponds to the number indicating a curve
in the graph.
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on the observation of unbinding by pulling vesicles with
magnetic tweezers. The forces measured by this technique
were systematically much smaller then expected (45). Results
of those experiments are consistent with the results presented
herein for antibody-induced vesicle unbinding. Even low
force can have large impact on the ensemble of bonds in the
contact zone. Rather than providing the resistance to pulling
typical for a single bond, bonds in the contact zone reor-
ganize to increase the spreading pressure of the vesicle. In
terms of antibody-induced unbinding, such reorganization
results in the formation of new microdomains (see Fig. 3).
This increased binding is typical for phase II, but has also
been observed by the end of phase I, particularly for inter-
mediate coverage (data not shown). Hence, the lateral pres-
sure exhibited by antibodies, if not too strong, can actually
stabilize the ligand-receptor mediated adhesion. This is
simply the result of the balance between the entropy and the
enthalpy of ligand-receptor binding.
Increased probability of ligand-receptor binding is also
the reason why it is so hard to completely destroy the last
remaining microdomains. This phenomenon manifests itself
in the sigmoid tail present in both the experimental data (Fig.
5) and the theoretical model (Fig. 10). These data show that
the presence of antagonists can clearly regulate the area in
which the ligand-receptor binding occurs, strongly preferring
formation of spatially localized multiple bonds between
ligands and receptors.
This approach is not only a valuable tool in characterization
of antagonist-induced unbinding of toy cells; it can also help
to clarify the mechanisms of analogous processes in nature.
For example, the role of elastase as a competitive binder in
the process of deadhesion of polymorphonuclear leukocytes
(30) can be related to the mechanisms characterized herein.
Indications that the binding between the elastase and CD11b
integrins in polymorphonuclear neutrophils occur have
recently been suggested (46). Although, no reliable proof is
yet available, it could be anticipated that the role of the
elastase recognized in vitrowill be related to its role in vivo. In
a similar fashion, the integrin receptors of type aVb3 in
endothelial cell are known to bind selectively to ﬁbronectin
coupled to the inner wall of the blood vessels. The ﬁbronectin
mediated adhesion can be counteracted by other molecules of
the extracellular matrix such as hyaluronic acid. This giant
polysaccharide is well known to inhibit tight adhesion by
binding to the cell surface of mesenchyme cells through
lectin-analog cell-surface receptors CD44. The mechanisms
for this interference in vivo are expected to be closely related
to these in the model systems as identiﬁed and characterized
herein.
In summary, the presented method is a stepping stone in
the development of a new powerful method for systematic
studies of the binding strength of cell-surface receptors to
their conjugate ligands in the extracellular matrix, under bio-
analog conditions. Alternatively, the method provides
a means with which to measure binding forces between
membrane-bound antibodies and antigens. It also demon-
strates the regulative role that inhibitive binding can have on
a speciﬁc interaction, and identiﬁes the physical origin of the
two deadhesion control mechanisms.
It is clear that this toymodel devoid of actin cortices can only
provide valuable insight into the primary step of the adhesion
and deadhesion process such as the nucleation and growth
of receptor clusters. On the other side methods have been
developed that allow the reconstitution of cortices of entangled
or cross-linked actin into giant vesicles (47) to generate more
realistic mechanical models of cell envelopes. Further rami-
ﬁcations of that systemwould require adding proteins involved
in the control of self-assembly of focal contacts such as talin
and vinculin or proteinsmediating the activity of these proteins
(such as GTPases of the rho family). In this case it would be
relatively easy to generate still primitive but active models of
cell envelopes, which would allow us to study the control
mechanisms of adhesion and deadhesion processes under new
and very exiting bio-analogous conditions.
This work has been sponsored by Sonderforschungsber-
eich under program No. 563 C4 and by the Fonds der
Chemischen Industrie. A.-S. Smith thanks the Hochschul-
und Wissenschaftsprogramm (HWP II) for support.
APPENDIX A: ANALYSIS OF
EXPERIMENTAL DATA
In this appendix we provide details of our data analysis. There are two
important tasks, each requiring several steps, which must be accomplished
to acquire relevant data. The ﬁrst task is to deﬁne the contact zone in the
collected pictures and translate it into real units. The second task is to
determine the areas in the contact zone that are tightly bound to the substrate.
The steps for both are somewhat interconnected and hence we summarize
the procedure in Fig. 12.
The planar distance (x and y) are, in raw data, given in pixels. The
conversion to real units is trivial by use of the scale bar. The vertical
dimension (h) is given by the intensity of the gray color. The diffraction
pattern is such that the interference closest to the substrate appears in the
darkest color and is set to be the zero height. This is because the lipid bilayer
height above the substrate is small compared to the wavelength. The simple
theory that considers only light that enters the sample in the direction normal
to the plane of the substrate provides a cosine law between the intensity of
the gray color and the distance from zero height (48). This approach gives
surprisingly good results for relative height differences ,100 nm and
permits precise shape reconstructions up to 800 nm. The interference pattern
displays a periodic series of constructive and destructive interference that
results in the height difference between an adjacent interference minimum
and maximum of Dh ¼ l/4n ¼ 101.9 nm (l ¼ 546.1 and is the wavelength
of the incident light; n ¼ 1.34 and is the refractive index of the buffer).
To determine a law that maps the intensity of the gray color to the height,
ﬁrst a histogram of intensities must be determined for a typical frame.
Examples of such histograms can be found in the second row of Fig. 12. It is
evident that only a certain interval of intensities appears in a given set of data
(in the case of the presented vesicle, only intensities between 100 and 180
out of 255 appear). It is on this interval that an inverse cosine transformation
must be performed to obtain the height, as presented in the top left corner in
Fig. 13. If one would be determining the heights.100 nm, the periodicity of
the cosine function should be taken into account. However, we restrict our
discussion to the heights ,100 nm where the important events in our
experiments take place.
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FIGURE 12 Schematic presentation of the data analysis procedure. Two frames, one from the beginning and one from the end of the deadhesion experiment,
are analyzed in parallel. The procedure is presented in parallel for two frames. The scheme is organized in rows, alternating the white and gray background
color of the row, each row representing a particular stage of the procedure. (First row) Graph where the intensity of the gray color is correlated to the height
above the substrate (left). Original frames are shown with the outline of the edge of the contact zone (middle). Histogram of heights constructed from the
analysis of the dependence of the height of the membrane in 15 different points in the contact zone (right). The area shaded in gray denotes the heights that are
associated with the bound membrane and provides the cutoff for the bound state. (Second row) Extraction of the contact zone (the 100 nm closest to the
substrate). The resulting frames are presented in the middle. On the sides, the proﬁles of the lines that are marked on the frames are shown. The histogram of
intensities presented exactly for the resulting frames is also given. Note that the range of gray colors in these histograms is the same as the range of intensities
that are transformed into heights (ﬁrst row, left). (Third row) Frames resulting from the height transformation according to the graph in the ﬁrst row, left.
Corresponding line proﬁles and height distributions are given. Note that the transformation uses now all 255 colors, but it is not changing the shape of the line
proﬁle nor the histogram. Gray areas in the graph are representing the bound part of the membrane. The upper boundary of these areas corresponds to the same
cutoff height (37 nm) as determined from the membrane ﬂuctuation analysis (ﬁrst row, right). (Last row, sides) Extraction of the strong adhesion by the
imposition of a threshold upon the frames from the fourth row at 37 nm. (Last row, middle) For better visualization of the contact zone, the brightness and the
contrast of the frames from the fourth row is performed. For details, see text.
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As the contact zone is deﬁned as the area of the vesicle that is most
proximal to the substrate, we extract the contact zone by ﬁnding the ﬁrst
bright rim (height of 100 nm). That is a relatively simple task that can be
performed by any image analysis program. Two examples of such edges are
presented in the top row of Fig. 12, where they overlay frames from the
beginning of the deadhesion process and from the end of the experiment,
respectively. Once the edge of the contact zone is deﬁned, the remaining
information from higher layers is discarded (second row of Fig. 12).
It is now that the conversion from intensities to height can be performed
(see third row in Fig. 12), and fulﬁll the ﬁrst task. After the mapping, all 255
colors are used, and hence, stronger contrast is obtained in the contact zone.
This can be clearly seen by comparing the histograms of intensities to the
histograms of heights (second and third row in Fig. 12, respectively). A
similar conclusion can be obtained by comparing the relevant line proﬁles,
also presented in the second and third row of Fig. 12.
To determine which part of the membrane is strongly adhered to the
substrate, the ﬂuctuation analysis of the contact zone had to be performed. In
this respect, the height ﬂuctuations in time are measured during the adhesion
and deadhesion processes for 15 points (squares of 6 3 6 pixels to decrease
the inﬂuence of noise), uniformly distributed over the contact zone. Typical
examples of such dependence can be seen in Figs. 1 and 3. From the
dependence of height on time, it is possible to construct a histogram of
heights for each point (top right corner graph in Fig. 13 is the overlay of
results for all 15 points). It is clear that the bound state possesses a certain
width imposed by the ﬂuctuations. For the chosen set of data, if a given point
experienced strong adhesion, a Gauss-like peak typically appears in the
histogram with a maximum around 26 nm. The intensity of the peak
certainly depends on the relative time that the given point has spent in the
state of strong adhesion. For example, if the point has never been strongly
adhered, the peak will not be evident in the histogram at all. We choose to
deﬁne strong adhesion if the height of the membrane is below 37 nm (shaded
gray in the histograms in Fig. 12). Although such a choice is somewhat
arbitrary, it is made after realizing that all well-deﬁned isolated peeks
(analysis of only the times while the point is strongly adhered), have a
maximum with the deviation of 13s below 37 nm. This choice is con-
sistently maintained for all analyses of the sample.
The imposition of a threshold in the histogram of heights at h ¼ 37 nm
provides the pictures in the bottom corners of Fig. 12. By counting the black
pixels in these frames, it is possible to build the dependence of the strongly
adhered membrane as a function of time or other relevant parameters such as
the concentration of antagonist inducing the deadhesion (Fig. 5). Sometimes,
for the purpose of clarity (but not for quantitative data analysis), it is possible
to increase the contrast and the brightness in the pictures. In such a way, tight
contacts are easy to observe by eye. Such a procedure has been used for the
construction of frames in the middle of the bottom row in Fig 13, but also for
the construction of the second row in Fig. 2 as well as for the entire Fig. 3. In
the latter, again for visualization purpose, the gray 255 intensity scale was
replaced by a red or blue 255 intensity scale, in a simple consecutive manner
starting by replacing the darkest gray with the darkest red (or blue).
Discussion of errors
There will be several contributions to the errors in acquired data for the area
of strong contact. The most obvious error is related to the deﬁnition of the
cutoff for the height at which speciﬁc adhesion occurs. However, as long as
all data are analyzed with the same cutoff, the functional dependence of the
area of strong contact with time or other parameters will not be inﬂuenced.
Rather a vertical shift in the data will be obtained as a ﬁrst-order inﬂuence.
The size of the contact has a second order inﬂuence. The procedure of
ﬁnding an edge or imposing a threshold results in an error that is propor-
tional to the ratio of the circumference to the area of the contact. Due to the
irregular shape of the contacts, large areas are generally favored. Further-
more, when the vesicle is relatively tense, the amplitudes of ﬂuctuations of
free membrane are lower, resulting in a very well-deﬁned peak for the bound
state (see the histograms of height in the third row of Fig. 12). Then, the
distinction between the free and bound membrane is clear. However, such
situations are usually attributed to large contact zones and large areas of
strong contact. When the area of strong contacts becomes small, then the
ﬂuctuations of the free membrane increase in amplitude, often approaching
the substrate without making a speciﬁc bond. As a result the shape of the
peak that belongs to the bound state is blurred around the cutoff (histograms
on the right side of the third row in Fig. 12).
One additional effect can be observed when comparing the line proﬁles
for large and small areas of strong contact (left- and right-hand graphs in the
third row of Fig. 12, respectively). For large contact zones, the bound part of
the membrane is well below 37 nm (in proﬁles seen as the edge of gray
areas). At small contact zones the entire proﬁle is lifted, due to ﬂuctuations
of the free membrane to higher values and the regions of strong contact only
barely penetrate below 37 nm, possibly indicating a stretching of the bonds.
The provided analysis is not able to account for such ﬁne details of the
deadhesion process.
Last but not least is certainly the question of proportionality of the area to
the number of formed bonds. At this stage there is no technique that would
allow us to directly measure the number of formed bonds. However, ex-
tensive analysis of membrane ﬂuctuations in the contact zone made us
conﬁdent that the density of receptors on used substrates is sufﬁciently large
and uniform so that the proportionality between the bound membrane and
number of bonds is preserved, at least to the ﬁrst order of magnitude.
APPENDIX B: PHASE I, THE
QUANTITATIVE ANALYSIS
The free energy (in units of kBT) of antibodies per unit surface area (area of
a site) covered by receptors consists of the binding enthalpy and the mixing
entropy terms for the antagonist absorbed on a receptor site and a free site:
Fa ¼ Ebpb1 pb ln pb1 ðrr  pbÞlnðrr  pbÞ
1 pf ln pf 1 ð1 rr  pfÞlnð1 rr  pfÞ: (8)
Minimizing the free energy and solving dF/dpb ¼ dF/dpf ¼ m results in pb,
and pf given in Eq. 5. The result of such a procedure is shown in Fig. 13.
When Eb is small and rr , 0.5, pf is the dominant contribution. At large
Eb, as well as at high coverage, pf can be omitted from pa as it is much
smaller than pb. However, it is important to note that, for ﬁxed concen-
trations of both antibodies and receptors, pa varies from zero to its maximum
value in range of 0, Eb, 20 kBT. Further increases in binding strength do
FIGURE 13 Coverage of the surface by antibodies as a function of the
antibody concentration in the solution Cv. At low concentrations of
antibodies in the solution pf is considerably smaller than pb. As the Cv
increases, pb saturates to rr indicating that all the receptors on the surface are
bound with antibodies.
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not signiﬁcantly inﬂuence the number of bound antibodies on the substrate.
For typical concentrations Cv , 0.1 and large antibody-receptor binding
strengths, the density of antibodies on the substrate saturates (pa / rr).
In this regime, antibodies occupy all of the receptors on the surface. An
increase of Cv above concentrations of 0.1, leads to signiﬁcant contribu-
tions of antibodies not bound to receptors but adsorbed on the surface pf.
However, such high densities of antibodies should be avoided in an
experiment because they induce considerable changes in the reduced volume
of the vesicle. In addition, in this limit, the description of absorption by
Langmuir isotherms fails to provide accurate results.
The lateral pressure of antibodies P is by deﬁnition the gain in the free
energy when the system increases its surface area for the area of of a unit site
(P[ dF=da ¼ Faðpb; pfÞ). Substituting Eq. 5 and into Eq. 8 upon reor-
ganizing results in the antibody lateral pressure given by Eq. 6.
Finding the limit of Eq. 6 when Eb / 0, one obtains that the lateral
pressure becomes independent of the concentration:
P0 ¼ ð1 rrÞlnð1 rrÞ  rr ln rr: (9)
In the case of a ﬁxed concentration (left panel in Fig. 14), the shape of the
curve is determined by the ﬁrst two terms on the right-hand side of Eq. 6.
Moreover, in the regime of large binding strengths (Eb . 10), the antibody
lateral pressure can be approximated by:
Pa ¼ Ebrr1P0: (10)
On the other hand, for a ﬁxed antibody binding strength, the lateral
antibody pressure reaches saturation with increasing the concentration (right
panel in Fig. 14). In the case of large binding strengths this saturation
value is:
Ps ¼ Pa1 ð1 rrÞ ln 2: (11)
Hence, in case of low antibody binding strength, it is possible that Ps,w0,
and that increasing the antibody concentration does not result in the
unbinding of the vesicle. However, in the regime of experimentally relevant
concentrations of antibodies the lateral pressure is changing rapidly and
small changes in the concentrations can induce a large impact on the size of
the contact zone.
APPENDIX C: PHASE II, THE CONSTRUCTION
OF THE FREE ENERGY
In a manner analogous to that used for modeling adhesion in the absence of
antibodies (31), the number of conformations of antibodies and ligands over
sites of the substrate in the contact zone occupied and unoccupied by
receptors is found to be:
V ¼ ð1 scÞStð1 nf  nbÞntSt















It is this number of conformations that is determining the entropy of the
vesicle-antagonists-substrate system. Furthermore, the binding of both the
antibodies and the ligands to the receptors contributes to the internal energy.
This leads to a total free energy in units of kBT for a ﬁnite vesicle with
a constant size of the contact zone:
F ¼ lnV EbpbscSt  EanbSt: (13)
For the ﬁxed size of the contact zone (sc) this free energy must be minimized.
Henceforth, the equations dF/dpb ¼ dF/dpf ¼ lnCv are solved simulta-
neously with dF/dnb¼ dF/dnf¼ 0, to obtain the results given by Eq. 7 and in
Figs. 9 and 10.
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